PatientCare Editorial Staff

November 03, 2021

A glance at therapeutic strategies being investigated to improve the treatment and outcomes of patients with ulcerative colitis and Crohn disease.

November 03, 2021

How to best treat a patient with inflammatory bowel disease who demonstrates no disease response to initial biologic treatment, as well as insight surrounding the treatment of patients who develop perianal disease.

November 03, 2021

Recommendations for monitoring a 24-year-old woman treated with biologic therapy to manage inflammatory bowel disease to evaluate treatment efficacy.

October 27, 2021

Factors that impact which biologic therapy a gastrointestinal specialist may initiate for a patient with inflammatory bowel disease, especially during the COVID-19 pandemic.

October 27, 2021

Recommendations when assessing response to biologic therapies used to treat ulcerative colitis and Crohn disease.

October 20, 2021

What to know in terms of integrating new oral, small molecule targeted drugs into treatment plans for patients with ulcerative colitis.

October 20, 2021

A review of various classes of biologic therapies available to treat patients with ulcerative colitis or Crohn's disease.

October 12, 2021

GI specialists review the case of a 24-year-old woman who presents with symptoms that suggest inflammatory bowel disease and suggest how they would appropriately test and diagnose the patient before initiating therapy.

October 12, 2021

Criteria used by gastroenterologists to evaluate patients with an inflammatory bowel disease for relapses or disease progression.

October 06, 2021

Red flag symptoms that should prompt a primary care physician to refer a patient to a gastroenterologist for proper assessment for a potential inflammatory bowel disease.